Page last updated: 2024-09-03

nk 252 and Leukemia P388

nk 252 has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kiue, A; Kohno, K; Kuwano, M; Naito, A; Okumura, M; Sano, T1
Inada, H; Kikuchi, J; Kiue, A; Kohno, K; Naito, A; Okumura, M; Sano, T; Sato, S; Suzuki, K; Takano, H1

Other Studies

2 other study(ies) available for nk 252 and Leukemia P388

ArticleYear
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
    British journal of cancer, 1991, Volume: 64, Issue:2

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice

1991
Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
    Japanese journal of cancer research : Gann, 1990, Volume: 81, Issue:10

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Dactinomycin; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Leukemia P388; Male; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Tritium; Vinblastine; Vincristine; Vindesine

1990